HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Breast Cancer Update
00:00
What is an antibody-drug conjugate and how does it work?
Dr Huppert explains ADC structure, targeting, intracellular trafficking, payload release, and the bystander effect.
Play episode from 00:38
Transcript
